To highlight the increasing prevalence of infectious diseases among individuals with substance use disorders (SUDs) and the urgent need for integrated care approaches.
Key Findings:
There is a significant increase in infectious diseases, including HIV, hepatitis, and STIs, among individuals with SUDs, as evidenced by recent studies.
Barriers to HIV prevention, such as adherence to daily oral PrEP, necessitate the exploration of long-acting injectable PrEP options, which may offer a solution.
Disparities in access to hepatitis C treatment persist, particularly among marginalized populations, highlighting the need for targeted interventions.
Routine STI testing is essential for PWID, with a reported 6% positivity rate for STIs in certain studies, underscoring the need for regular screenings.
Interpretation:
The findings underscore the urgent need for integrated care models that address the complex health and social needs of PWUD, including specific examples of successful interventions.
Limitations:
The studies may not fully capture the experiences of all PWUD due to varying access to healthcare resources, particularly in rural areas.
Barriers to care and treatment uptake were often reported but not comprehensively addressed in all studies, indicating a gap in understanding.
Conclusion:
Addressing the syndemic of infectious diseases among PWUD requires innovative, integrated approaches to care that consider both health and social determinants, ensuring equitable access to services.
